Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report

Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report

Bibliographic Details
Main Author: Christopher E. Rudd
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Pharmacology
Subjects:
lithium
COVID-19
GSK-3
SARS CoV2
viral replication
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.613734/full
id doaj-985281fb87b941a6882e1bd4831d1550
record_format Article
spelling doaj-985281fb87b941a6882e1bd4831d15502020-12-16T05:40:28ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-12-011110.3389/fphar.2020.613734613734Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case ReportChristopher E. Rudd0Christopher E. Rudd1Christopher E. Rudd2Centre de Recherche- Maisonneuve-Rosemont Hospital (CR-HMR), Montreal, QC , CanadaDépartement de Medicine, Université de Montréal, Montreal, QC, CanadaDepartment of Medicine, Division of Endocrinology & Medical Biochemistry, McGill University Health Center, Montreal, QC, Canadahttps://www.frontiersin.org/articles/10.3389/fphar.2020.613734/fulllithiumCOVID-19GSK-3SARS CoV2viral replication
collection DOAJ
language English
format Article
sources DOAJ
author Christopher E. Rudd
Christopher E. Rudd
Christopher E. Rudd
spellingShingle Christopher E. Rudd
Christopher E. Rudd
Christopher E. Rudd
Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
Frontiers in Pharmacology
lithium
COVID-19
GSK-3
SARS CoV2
viral replication
author_facet Christopher E. Rudd
Christopher E. Rudd
Christopher E. Rudd
author_sort Christopher E. Rudd
title Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
title_short Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
title_full Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
title_fullStr Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
title_full_unstemmed Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
title_sort commentary: does lithium deserve a place in the treatment against covid-19? a preliminary observational study in six patients, case report
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2020-12-01
topic lithium
COVID-19
GSK-3
SARS CoV2
viral replication
url https://www.frontiersin.org/articles/10.3389/fphar.2020.613734/full
work_keys_str_mv AT christophererudd commentarydoeslithiumdeserveaplaceinthetreatmentagainstcovid19apreliminaryobservationalstudyinsixpatientscasereport
AT christophererudd commentarydoeslithiumdeserveaplaceinthetreatmentagainstcovid19apreliminaryobservationalstudyinsixpatientscasereport
AT christophererudd commentarydoeslithiumdeserveaplaceinthetreatmentagainstcovid19apreliminaryobservationalstudyinsixpatientscasereport
_version_ 1724381649585569792

Similar Items